| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 01/25/2006 | CN1724531A Method of extracting proto anthocyanidin by supercritical extraction grape seed oil and resin absorption |
| 01/25/2006 | CN1724530A Method of chromatography preparing high purity EGCG by continous medium-pressure column |
| 01/25/2006 | CN1724529A High purity cnidicin and its preparation method and medicinal composition using said compound as active component |
| 01/25/2006 | CN1238356C Method for extracting tetrodotoxin |
| 01/25/2006 | CN1238350C Purification method of raw anthocyanidin oligomer |
| 01/25/2006 | CN1238323C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 01/25/2006 | CN1237896C Method for producing base material of soybean isoflavone with sugariness taste |
| 01/24/2006 | US6989446 Reacting an aromatic carbonyl compound with carbon monoxide in presence of a metal catalyst |
| 01/24/2006 | CA2182506C 4-(alpha-methoxy)methylene-2h-chromene-3(4h)-one and its use in agriculture |
| 01/19/2006 | WO2006007436A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders |
| 01/19/2006 | WO2006007435A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders |
| 01/19/2006 | US20060014967 Process for isolating of alpha-mangostin |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | CA2581674A1 Indoleamine 2,3-dioxygenase (ido) inhibitors |
| 01/19/2006 | CA2570614A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders |
| 01/18/2006 | EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes |
| 01/18/2006 | EP1615906A1 Compositions useful as inhibitors of protein kinases |
| 01/18/2006 | EP1615905A2 Benzopyran compounds useful for treating inflammatory conditions |
| 01/18/2006 | EP1615892A2 Benzamide 2-hydroxy-3-diaminoalkanes |
| 01/18/2006 | EP0973727B8 Activated iododerivatives for the treatment of cancer and aids |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/18/2006 | CN1237119C Dopant agent and electroconductive polymer materials comprising the same |
| 01/18/2006 | CN1237066C Antihyperglycemic and oxidation resistant health products and preparing process thereof |
| 01/17/2006 | US6987194 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 01/17/2006 | US6987126 Neutralizing agent for clostridium bacterial neurotoxins and preparation method thereof |
| 01/12/2006 | WO2006003458A1 Pyrans for use in the treatment of infection |
| 01/12/2006 | WO2006002918A2 Use of trisubstituted benzopyranones |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | CA2570908A1 Use of trisubstituted benzopyranones |
| 01/12/2006 | CA2570533A1 Substituted hydroxyacetophenon derivatives |
| 01/11/2006 | EP1614756A1 A combinatorial polyketide library |
| 01/11/2006 | EP1614685A1 Process for preparing 2-chloro-6-Halogeno-3-alkyl-4H-chrom en-4-one or 2-chloro-3-alkyl-4H-chromen-4-one derivatives |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1613578A2 Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol |
| 01/11/2006 | EP1613311A2 Hif-1 inhibitors |
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/11/2006 | CN1718578A Lerivisiticum extract, its preparation method and medicine containing said extract |
| 01/11/2006 | CN1718576A Synthesis method of flavonoid compound capram pyrane |
| 01/11/2006 | CN1235925C Solid phase synthesing method of aldehyde, ketonic, oxime, amine and isohydroximic acid compound |
| 01/11/2006 | CN1235855C Process for preparation of bicyclic diketone salts |
| 01/10/2006 | US6984718 Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 01/10/2006 | US6984515 Macrolide analogs |
| 01/05/2006 | US20060004023 Treatment for attention-deficit hyperactivity disorder |
| 01/05/2006 | US20060002853 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 01/05/2006 | CA2572135A1 Sulfonamide compound |
| 01/04/2006 | EP1611119A1 Pi-3 kinase inhibitor prodrugs |
| 01/04/2006 | EP1546391A4 Energy transfer dyes, terminators and use thereof |
| 01/04/2006 | EP1546125A4 Fluorescent labeling reagents with multiple donors and acceptors |
| 01/04/2006 | EP1472514A4 Method of preparing delta-9 tetrahydrocannabinol |
| 01/04/2006 | CN1717405A Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 01/04/2006 | CN1715283A Novel garcinolic acid derivative and its preparing method and use |
| 01/04/2006 | CN1715279A Repinotan analogue,its preparing method and use |
| 01/04/2006 | CN1715277A Compound for treating cardiocerebral vascular disease and its preparing method and its use in pharmaceutical field |
| 01/04/2006 | CN1234703C Prepn process of high-purity mixed tocopherol |
| 01/04/2006 | CN1234702C Benzopyran compound, and pharmaceutical composition including them |
| 01/04/2006 | CN1234681C Amino acid derivatives and their use as pesticides |
| 01/04/2006 | CN1234679C Shortened synthesis of 3, 3-diaryl propylamine derivatives |
| 01/03/2006 | US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 12/29/2005 | WO2005123872A1 Polymerisable naphthopyran derivatives and polymer materials obtained from said derivatives |
| 12/29/2005 | WO2005123851A1 Environment -friendly pollution-proof agent extracted from sargassum |
| 12/29/2005 | WO2005123676A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers |
| 12/29/2005 | WO2004073658A3 Isoflavone derivatives |
| 12/29/2005 | US20050288359 Agents and methods for the treatment of disorders associated with oxidative stress |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288213 Combination therapy for the treatment of obesity |
| 12/29/2005 | US20050284812 Process for preparing water soluble diterpenes and their applications |
| 12/29/2005 | CA2570258A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers |
| 12/29/2005 | CA2569705A1 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof |
| 12/29/2005 | CA2567629A1 Polymerisable naphthopyrane derivatives and polymer materials obtained from these derivatives |
| 12/28/2005 | EP1610126A1 A system for determining the electrical potential across a membrane |
| 12/28/2005 | EP1608643A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 12/28/2005 | EP1254131B8 Extraction of flavonoids |
| 12/28/2005 | EP1024802B1 Cannabinol-11-oic acid derivatives useful as antiinflammatory agents and analgesics |
| 12/28/2005 | CN1714079A Mandelic acid derivatives |
| 12/28/2005 | CN1712402A Extraction of dihydromyricetin from microwave and composition thereof |
| 12/28/2005 | CN1712401A Separation and preparation of blushed rabdosia extract-A as check sample |
| 12/28/2005 | CN1233639C Extraction of soya isoflavone from waste soybean serum |
| 12/28/2005 | CN1233638C Method for producing isoforaxidin, eleutheroside and eleutheran from Radix Acanthopanacis senticosi |
| 12/27/2005 | US6979743 Cooling, crystallizing in a hydrocarbon solvent mixture containing methanol, producing high yield and pure sterols, a transesterification products from rapeseed oil or sunflower oil distillation residue; food additives, anticholesterol agents |
| 12/22/2005 | WO2005121117A1 Processes for production of optically active compounds |
| 12/22/2005 | WO2005121116A1 Chromone derivatives useful as vanilloid antagonists |
| 12/22/2005 | WO2005121115A1 PROCESS FOR THE MANUFACTURE OF CHROMAN DERIVATIVES, ESPECIALLY α-TOCOPHEROL AND ALKANOATES THEREOF |
| 12/22/2005 | WO2005060663A3 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 12/22/2005 | US20050282889 Intracorporeal medicaments for photodynamic treatment of disease |
| 12/22/2005 | US20050282887 Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| 12/22/2005 | CA2569113A1 Chromone derivatives useful as vanilloid antagonists |
| 12/21/2005 | EP1607393A1 Compositions comprising hydroalkylated direct dyestuffs, process for implementing and use |
| 12/21/2005 | EP1605904A2 Reduction of hair growth |
| 12/21/2005 | CN1709887A Method for preparing high-purity tea polypenols |
| 12/21/2005 | CN1709886A Method for extracting total isoflavone from herb of red clover |
| 12/21/2005 | CN1709885A Total flavone glycoside extract of Radix scutellariae, Rodix scutellariae monomer flavone glycoside, its preparation and use |
| 12/21/2005 | CN1709884A Extracted product from leaves of podocarpus and preparation method and use |
| 12/21/2005 | CN1232480C Process for the preparation of nitroalkenes |
| 12/20/2005 | US6977255 8-Substituted 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-ones inhibitor of phosphoinositide (PI) 3- kinase, an enzyme that regulates platelet-adhesion (antithrombotic agent) |
| 12/15/2005 | US20050277777 Process for the manufacture of chroman derivatives, especially alpha-tocopherol and alkanoates thereof |
| 12/15/2005 | US20050275341 Absorption and luminescent maxima in the visible region, effectively absorb the visible light, emit the visible light when excited, have a significantly high thermostability; electroluminescent elements; durability |
| 12/15/2005 | US20050274929 Fluorinated xanthenes and use thereof in liquid-crystal mixtures |
| 12/15/2005 | DE102004025791A1 Chromanol-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Chromanol derivatives, a process for their preparation and their use as anti-inflammatories |